Mainstay Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Buy |
+5,838
| New | +$403K | 0.02% | 116 |
|
|
2025
Q1 | – | Sell |
-2,566
| Closed | -$221K | – | 114 |
|
|
2024
Q4 | $221K | Buy |
2,566
+44
| +2% | +$3.79K | 0.03% | 99 |
|
|
2024
Q3 | $300K | Hold |
2,522
| – | – | 0.05% | 86 |
|
|
2024
Q2 | $360K | Buy |
2,522
+13
| +0.5% | +$1.86K | 0.06% | 75 |
|
|
2024
Q1 | $322K | Buy |
2,509
+49
| +2% | +$6.29K | 0.06% | 85 |
|
|
2023
Q4 | $254K | Buy |
+2,460
| New | +$254K | 0.05% | 94 |
|
|
2023
Q3 | – | Sell |
-2,670
| Closed | -$216K | – | 105 |
|
|
2023
Q2 | $216K | Buy |
+2,670
| New | +$216K | 0.04% | 101 |
|